Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for BLUTPLASMABIOMARKER FÜR BEVACIZUMAB-KOMBINATIONSTHERAPIEN ZUR BEHANDLUNG VON PANKREASKARZINOM
Details for 2011748601
Up to date per 10.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2011748601
Title / Product Name
BLUTPLASMABIOMARKER FÜR BEVACIZUMAB-KOMBINATIONSTHERAPIEN ZUR BEHANDLUNG VON PANKREASKARZINOM
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2011748601
EP Publication Number
2596364
E-Number
765806
Language
EN
PCT Number
EP11062226
Publication Date
29.05.2013 A
16.12.2015 B1
Registration Date
16.12.2015
AT Publication Date
15.01.2016
Application Date
18.07.2011
Registration Number
-
Priorities
19.07.2010
EP
10170004
IPC
G01N 33/574 20060101AFI20120206BHEP
Maximum Duration of Protection
18.07.2031
Owner
F.Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel
CH
Representative
No representatives present
Inventor
DELMAR, Paul
Hammerstrasse 89
CH-4057 Basel
CH
FOERNZLER, Dorothee
Eisengasse 16
CH-5600 Lenzburg
CH
KRAUSE, Friedemann
An der Freiheit 150
82377 Penzberg
DE
SCHERER, Stefan
c/o Genentech Inc. 1 DNA Way South San Francisco
California 94080
US